The global electroencephalography (EEG) devices market is experiencing significant growth, driven by the rising prevalence of neurological disorders, advancements in technology, and increasing awareness of mental health issues. EEG devices are essential tools for diagnosing and monitoring conditions such as epilepsy, sleep disorders, brain tumors, and other neurological abnormalities. The market is characterized by continuous innovations, including portable and wireless EEG devices, which enhance patient mobility and convenience. Additionally, the integration of artificial intelligence and machine learning in EEG systems is improving the accuracy and efficiency of data analysis, thereby facilitating better clinical outcomes. The growing demand for non-invasive diagnostic tools, coupled with expanding applications in research and clinical settings, is further propelling the market.
Global Electroencephalography Devices Market was valued at USD 1,110.68 million in 2021 and is expected to reach USD 1,726.61 million by 2029, registering a CAGR of 5.40% during the forecast period of 2022-2029.
To know more, visit https://www.databridgemarketresearch.com/reports/global-electroencephalography-devices-market
Below are the Top Five Electroencephalography Devices Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
Medtronic
|
Medtronic offers advanced solutions that integrate cutting-edge technology and innovative design to improve neurological health. Their EEG devices are utilized for monitoring and diagnosing neurological disorders, providing accurate and reliable data for clinical decision-making. Medtronic's commitment to research and development ensures that its EEG devices are at the forefront of medical technology, catering to both clinical and research needs.
|
|
North America, Middle East and Africa, Europe, South America, Asia-Pacific
|
In November 2020, Medtronic announced that it has been ranked as one of the leading firms for sustainability by the Dow Jones Sustainability North America Index (DJSI North America). This recognition received by the company has increased its credibility in the market leading to increased demand for its product in the market.
|
|
2.
|
NIHON KOHDEN CORPORATION
|
NIHON KOHDEN offers a comprehensive range of EEG devices renowned for their precision and reliability. Their EEG systems are designed to facilitate accurate diagnosis and treatment of neurological conditions, enhancing patient care and outcomes. NIHON KOHDEN's EEG devices are widely used in hospitals, clinics, and research institutions, demonstrating the company's commitment to advancing neurological health through innovative technology.
|
EEG
|
North America, Middle East and Africa, Europe, South America, Asia-Pacific
|
In August 2020, NIHON KOHDEN CORPORATION launched Version 12 of the Polysmith software used in Polysomnography Devices. This new version of software launched by the company includes more than 40 market-driven features which aids in good analysis and outcomes. Thus, this product launch by the company has increased the demand for its sales and market in future.
|
|
3.
|
Masimo
|
Masimo specializes in sophisticated EEG monitoring solutions designed to provide accurate and reliable brain activity data. Masimo's EEG devices are known for their ease of use, advanced features, and integration capabilities with other monitoring systems. These devices are used in diverse clinical settings, aiding in the diagnosis and management of neurological disorders, and reinforcing Masimo's reputation for high-quality, innovative medical technology.
|
|
North America, Middle East and Africa, Europe, South America, Asia-Pacific
|
In January 2021, Masimo has announced the global launch of iSirona, which is a compact, versatile connectivity hub designed to maximize interoperability across the continuum of care. This product launch anticipated to escalate company presence in the market.
|
|
4.
|
Natus Medical Incorporated
|
Natus Medical offers a wide range of EEG systems known for their accuracy, durability, and ease of use. Natus's EEG devices are utilized in hospitals, clinics, and research centers for the diagnosis and treatment of various neurological conditions. The company's commitment to innovation and quality ensures that their EEG devices meet the highest standards, providing reliable data for clinical decision-making.
|
Long-Term Monitoring (LTM)
|
North America, Europe, Asia-Pacific
|
In December 2020, Natus Medical Incorporated announced that it would be participating in the 13th Annual LD Micro Conference in order to create awareness about its product in the market. This participation by the company has increased its credibility in the market.
|
|
5.
|
Elekta
|
Elekta provides innovative EEG solutions designed to support the diagnosis and treatment of neurological disorders. Elekta's EEG devices are known for their advanced technology, high accuracy, and user-friendly interfaces. These devices are widely used in clinical and research settings, contributing to Elekta's mission of improving lives through precision medical solutions.
|
|
Americas, Europe, Asia, Australia
|
In May 2017, Elekta announced a long-term strategic partnership with BESA GmbH to collaborate on developing and commercializing clinical software solutions for MEG. The primary goal of this partnership is to deliver a top-tier workflow for pre-surgical evaluation of epilepsy patients.
|
Conclusion
The global electroencephalography (EEG) devices market is set for robust expansion, fueled by the increasing prevalence of neurological disorders, technological advancements, and heightened awareness of mental health. Innovations such as portable and wireless EEG devices and the integration of AI and machine learning are enhancing the accuracy and convenience of EEG systems. Key industry players are actively investing in research and development to bring advanced and user-friendly products to market. While North America remains the largest market due to its advanced healthcare infrastructure, the Asia-Pacific region is emerging as the fastest-growing market, driven by rising healthcare investments and awareness. Overall, the EEG Devices Market presents significant opportunities for growth and innovation, catering to both clinical and research needs.
